BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2036 related articles for article (PubMed ID: 32458193)

  • 1. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
    Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
    Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
    Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
    Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising evidence for neurological involvement in COVID-19 pandemic.
    Calcagno N; Colombo E; Maranzano A; Pasquini J; Keller Sarmiento IJ; Trogu F; Silani V
    Neurol Sci; 2020 Jun; 41(6):1339-1341. PubMed ID: 32394275
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurological manifestations of COVID-19: a review article.
    Niazkar HR; Zibaee B; Nasimi A; Bahri N
    Neurol Sci; 2020 Jul; 41(7):1667-1671. PubMed ID: 32483687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.
    Pennisi M; Lanza G; Falzone L; Fisicaro F; Ferri R; Bella R
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of COVID-19: available evidences and a new paradigm.
    Khatoon F; Prasad K; Kumar V
    J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.